See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2024_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 519,816,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 237,230,000 |
| 2 | PropertyPlantAndEquipmentNet | 44,593,000 |
| 3 | remainder_Assets | 102,783,000 |
| 4 | LiabilitiesCurrent | 145,477,000 |
| 5 | LiabilitiesNoncurrent | 289,628,000 |
| 6 | remainder_Liabilities | 11,718,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 349,791,712 |
| 9 | ResearchAndDevelopmentExpense | 32,234,421 |
| 10 | remainder_Expenses | 323,416,655 |
| 11 | remainder_Revenues | 1,338,223,240 |
| 12 | remainder_NetIncome | -27,062,500 |
| 13 | remainder_ComprehensiveNetIncome | -811,802 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 904,422,000 |
| 1 | Liabilities | 446,823,000 |
| 2 | Expenses | 705,442,788 |
| 3 | Revenues | 1,338,223,240 |
| 4 | StockholdersEquity | 457,599,000 |
| 5 | NetIncome | 605,717,952 |
| 6 | ComprehensiveNetIncome | 605,312,051 |
| 7 | BaseVar | 1,711,392,665 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.37 |
| 9 | EconomicCapitalRatio | 3.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
